Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0024141 (
systemic lupus erythematosus
)
44,322
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Genetic research in
systemic lupus erythematosus
(
SLE
) is rapidly developing, and numerous sets of genes are being associated with specific clinical subphenotypes in the setting of
SLE
. On the other hand, basic science studies are revealing strong connections between salt-water balance and inflammation. The aim of this study was to evaluate whether variants of genes known to influence the individual susceptibility to hypertension also influence the renal function in a cohort of
SLE
patients with and without lupus nephritis (LN). This study is a case-control study with candidate gene approach. A total of 111 patients with
SLE
(50 with
SLE
without nephritis, 55 with LN and 6 with simple urinary sediment abnormalities) and 62 healthy controls (HC) were genotyped for NCX1 rs11893826 (NCX1a) and rs434082 (NCX1b) and
ADD2
rs4984 SNPs. Patients with
ADD2
CT genotype were protected from LN and skin involvement;
ADD2
CC | NCX1a AA/AG genotypes were associated with the presence of anti-cardiolipin antibodies; NCX1a AA genotype was slightly more frequent in
lupus
patients than in HC and associated with relapse risk and higher creatinine in patients with LN. NCX1b GG patients with LN had increased chances to reach complete remission. NCX1b GG | NCX1a GG genotype is associated with joint involvement.
ADD2
and NCX1 variants influence the risk and the clinical features of
SLE
and LN, highlighting their potential role in regulating systemic inflammation and/or the local response to immune-mediated injury.
...
PMID:Beta-adducin and sodium-calcium exchanger 1 gene variants are associated with systemic lupus erythematosus and lupus nephritis. 2604 17